PH31403A - Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same. - Google Patents

Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.

Info

Publication number: PH31403A
Authority: PH; Philippines
Prior art keywords: therapeutic compositions; mammalian cells; saturated; mixture; methods
Prior art date: 1991-03-01

Application number

PH43765A

Other languages

English (en)

Inventor

Martin Alain

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-01

Filing date

1992-01-13

Publication date

1998-10-29

1992-01-13 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

1998-10-29 Publication of PH31403A publication Critical patent/PH31403A/en

Links

239000000203 mixture Substances 0.000 title abstract 13
230000001225 therapeutic effect Effects 0.000 title abstract 9
210000004962 mammalian cell Anatomy 0.000 title abstract 3
229920006395 saturated elastomer Polymers 0.000 abstract 4
235000003441 saturated fatty acids Nutrition 0.000 abstract 4
150000004671 saturated fatty acids Chemical class 0.000 abstract 4
235000021122 unsaturated fatty acids Nutrition 0.000 abstract 4
150000004670 unsaturated fatty acids Chemical class 0.000 abstract 4
239000003963 antioxidant agent Substances 0.000 abstract 3
230000003078 antioxidant effect Effects 0.000 abstract 3
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 2
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 abstract 2
239000000825 pharmaceutical preparation Substances 0.000 abstract 2
229940127557 pharmaceutical product Drugs 0.000 abstract 2
230000000699 topical effect Effects 0.000 abstract 2
208000027418 Wounds and injury Diseases 0.000 abstract 1
230000006378 damage Effects 0.000 abstract 1
208000014674 injury Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Birds (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Oral & Maxillofacial Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PH43765A 1991-03-01 1992-01-13 Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same. PH31403A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66350091A	1991-03-01	1991-03-01

Publications (1)

Publication Number	Publication Date
PH31403A true PH31403A (en)	1998-10-29

Family

ID=24662074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH43765A PH31403A (en)	1991-03-01	1992-01-13	Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.

Country Status (9)

Country	Link
EP (1)	EP0573465B1 (de)
JP (3)	JP3413803B2 (de)
AT (1)	ATE150966T1 (de)
CA (1)	CA2104461C (de)
DE (1)	DE69218762T2 (de)
MX (1)	MX9200894A (de)
PH (1)	PH31403A (de)
WO (1)	WO1992015292A1 (de)
ZA (1)	ZA921538B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5641814A (en) *	1991-03-01	1997-06-24	Warner-Lambert Company	Antikeratolytic-wound healing compositions and methods for preparing and using same
AU698682B2 (en) *	1991-03-01	1998-11-05	Warner-Lambert Company Llc	Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
US5856364A (en) *	1991-03-01	1999-01-05	Warner Lambert Company	Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5648380A (en) *	1991-03-01	1997-07-15	Warner-Lambert Company	Anti-inflammatory wound healing compositions and methods for preparing and using same
US5658956A (en) *	1991-03-01	1997-08-19	Warner-Lambert Company	Bioadhesive-wound healing compositions and methods for preparing and using same
US5614561A (en) *	1991-03-01	1997-03-25	Warner-Lambert Company	Antihistamine-wound healing compositions and methods for preparing and using same
US5602183A (en) *	1991-03-01	1997-02-11	Warner-Lambert Company	Dermatological wound healing compositions and methods for preparing and using same
AU711789B2 (en) *	1991-03-01	1999-10-21	Warner-Lambert Company Llc	Antibacterial-wound healing compositions and methods for preparing and using same
US5674912A (en) *	1991-03-01	1997-10-07	Warner-Lambert Company	Sunscreen-wound healing compositions and methods for preparing and using same
US5658957A (en) *	1991-03-01	1997-08-19	Warner Lambert Company	Immunostimulating wound healing compositions and method for preparing and using same
US5663208A (en) *	1991-03-01	1997-09-02	Warner-Lambert Company	Antifungal wound healing compositions and methods for preparing and using same
AU713829B2 (en) *	1991-03-01	1999-12-09	Warner-Lambert Company Llc	Immunostimulating wound healing compositions and methods for preparing and using same
US5646190A (en) *	1991-03-01	1997-07-08	Warner-Lambert Company	Acne treating-wound healing compositions and methods for preparing and using same
US5863938A (en) *	1991-03-01	1999-01-26	Warner Lambert Company	Antibacterial-wound healing compositions and methods for preparing and using same
WO1993016690A1 (en) *	1992-02-25	1993-09-02	Warner-Lambert Company	Cytoprotective compositions containing pyruvate and antioxidants
ATE196599T1 (de) *	1993-01-19	2000-10-15	Nicholas V Dr Perricone	Mittel zur topischen anwendung auf der haut zur behandlung und/oder zur verhütung von, durch strahlen verursachten hautschäden
DE4309512A1 (de) *	1993-03-25	1994-09-29	Beiersdorf Ag	Verwendung von cis-9-Heptadecensäure
EP0702950A1 (de) *	1994-09-26	1996-03-27	Beiersdorf Aktiengesellschaft	Verwendung von Fettsäuren gegen Superinfektionen der Haut
WO1996010474A1 (en) *	1994-09-30	1996-04-11	Warner-Lambert Company	Razor cartridges comprising wound healing compositions
FR2769535B1 (fr)	1997-10-15	1999-12-31	Bic Soc	Bande antifriction extrudee pour tete de rasage et tete de rasage comportant une telle bande
DE19830770C1 (de) *	1998-07-09	2000-05-18	Sueddeutsche Kalkstickstoff	Wasserlösliche Zinkpyruvate bzw. deren Hydrate, Verfahren zu ihrer Herstellung und deren Verwendung
US6432424B1 (en)	2000-06-29	2002-08-13	Johnson & Johnson Consumer Companies, Inc.	Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid
US6630175B1 (en)	2000-06-29	2003-10-07	Johnson & Johnson Consumer Companies, Inc.	Method of reducing eye irritation
US6649176B1 (en)	2000-06-29	2003-11-18	Johnson & Johnson Consumer Companies, Inc.	Compositions containing mineral water
US6372791B1 (en)	2000-06-29	2002-04-16	Johnson & Johnson Consumer Companies, Inc.	Method of promoting skin cell metabolism
US8076373B2 (en) *	2001-09-11	2011-12-13	North Cell Pharmacetical	Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
EP2653551B1 (de)	2010-12-13	2018-02-07	Kyowa Medex Co., Ltd.	Verfahren zur Messung einer Komponente, welche zu messen ist.
US20120252888A1 (en) *	2011-03-29	2012-10-04	Palupa Medical Ltd.	Compositions and Methods for Treating Neurologic Disorders
US10231941B2 (en)	2015-01-23	2019-03-19	Temple University—Of The Commonwealth System of Higher Educaton	Use of short chain fatty acids in cancer prevention
DE202019002134U1 (de)	2019-05-16	2019-06-06	Penta Phi Eg	Liposomales Glutathion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3123259A1 (de)	1981-06-12	1982-12-30	Werner Prof. Dr. 2400 Lübeck Thorn	"oral verabreichbares pharmazeutisches praeparat"
DE3719097C1 (de) *	1987-06-06	1988-06-09	Fratzer Uwe	Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E
GB8813766D0 (en) *	1988-06-10	1988-07-13	Efamol Holdings	Essential fatty acid compositions

1992
- 1992-01-13 PH PH43765A patent/PH31403A/en unknown
- 1992-01-15 JP JP50532992A patent/JP3413803B2/ja not_active Expired - Lifetime
- 1992-01-15 EP EP92904841A patent/EP0573465B1/de not_active Expired - Lifetime
- 1992-01-15 AT AT92904841T patent/ATE150966T1/de not_active IP Right Cessation
- 1992-01-15 DE DE69218762T patent/DE69218762T2/de not_active Expired - Lifetime
- 1992-01-15 WO PCT/US1992/000249 patent/WO1992015292A1/en not_active Ceased
- 1992-01-15 CA CA002104461A patent/CA2104461C/en not_active Expired - Lifetime
- 1992-02-28 ZA ZA921538A patent/ZA921538B/xx unknown
- 1992-02-28 MX MX9200894A patent/MX9200894A/es unknown
2002
- 2002-03-25 JP JP2002082387A patent/JP2002356421A/ja active Pending
- 2002-12-13 JP JP2002362245A patent/JP2003231632A/ja active Pending

Also Published As

Publication number	Publication date
JP3413803B2 (ja)	2003-06-09
ZA921538B (en)	1992-11-25
CA2104461A1 (en)	1992-09-02
AU668084B2 (en)	1996-04-26
CA2104461C (en)	2002-07-30
DE69218762T2 (de)	1997-11-06
DE69218762D1 (de)	1997-05-07
MX9200894A (es)	1992-09-01
WO1992015292A1 (en)	1992-09-17
EP0573465B1 (de)	1997-04-02
ATE150966T1 (de)	1997-04-15
JP2003231632A (ja)	2003-08-19
EP0573465A1 (de)	1993-12-15
JPH06506917A (ja)	1994-08-04
AU1271892A (en)	1992-10-06
JP2002356421A (ja)	2002-12-13

Publication	Publication Date	Title
PH31403A (en)	1998-10-29	Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.
MX9604271A (es)	1997-12-31	Composicion antiviral para curar heridas que contiene un piruvato, un antioxidante, una mezcla de acidos grasos y un compuesto antiviral.
NZ295303A (en)	1999-07-29	Sunscreen composition comprising a sunscreen agent, an anti-inflammatory agent and a composition for healing wounds
NZ308293A (en)	2000-01-28	Antibacterial-wound healing compositions comprising a pyruvate, antioxidant and fatty acids
MX9606501A (es)	1997-03-29	Composiciones antifungosas y curativas para heridas y metodos para preparar y utilizar las mismas.
MX9606502A (es)	1997-03-29	Composiciones antiqueratoliticas y curativas para heridas y metodos para preparar y utilizar las mismas.
NZ307055A (en)	2000-01-28	Immunostimulating-wound healing compositions and methods for preparing and using same
ZA885192B (en)	1989-04-26	Pharmaceutical preparations
DE2964963D1 (en)	1983-04-07	Medical food based on liver powder and process for its preparation
HUT55002A (en)	1991-04-29	Process for producing pyrimidine -4,6-dicarboxylic acid-diamides and pharmaceutical compositions containing them as active components
IT1170214B (it)	1987-06-03	Composizione farmaceutica per la cura delle arteriopatie periferiche
PT72507A (en)	1981-03-01	Process for the preparation of 3,4,5-trihydroxypiperidine derivatives having effect upon the carbohydrates and lipids metabolism and application thereof for the preparation of pharmaceutical and/or veterinary compositions having effect upon the carbohydrates and lipids metabolism
WO1987004926A3 (en)	1988-05-19	Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
ES8400028A1 (es)	1983-10-16	Metodo de preparacion de una composicion tixotropica anhidra.
SE8500033D0 (sv)	1985-01-04	Powder mixture having high propylene glycol content and process for the preparation thereof
SE8800988D0 (sv)	1988-03-18	Pharmaceutical compositons acting on the heart and cardiovascular system and process for preparing same
GB2021409A (en)	1979-12-05	Pharmaceutical composition
EP0400499A3 (de)	1991-07-31	Neue Acylaminosäurederivate enthaltende Arzneimittel und Diätetika
PL308580A1 (en)	1995-11-27	Solid pharmaceutical composition for oral administration and method of preparing same
KR930003913A (ko)	1993-03-22	덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
DE2965218D1 (en)	1983-05-19	2-hydroxymethyl-3,4,5-trihydroxy-piperidine derivatives, their preparation and medicaments containing them
NZ220800A (en)	1989-12-21	Tetrahydrobenzothiazoles and pharmaceutical compositions
ES8200363A1 (es)	1981-11-01	Procedimiento para la obtencion de esteres 4,5-dialquil-3- hidroxi-pirrol-2-carboxilicos
MX9708104A (es)	1998-01-31	Composiciones para sanar heridas inmunoestimulantes y metodos para preparar y utilizar las mismas.
ZA892101B (en)	1989-11-29	Salicylic acid containing pharmaceutical preparations for treating scaly skin diseases